ECSP034663A - PIRAZOL COMPOUNDS USED AS PROTEIN QUINASA INHIBITORS - Google Patents

PIRAZOL COMPOUNDS USED AS PROTEIN QUINASA INHIBITORS

Info

Publication number
ECSP034663A
ECSP034663A ECSP034663A ECSP034663A EC SP034663 A ECSP034663 A EC SP034663A EC SP034663 A ECSP034663 A EC SP034663A EC SP034663 A ECSP034663 A EC SP034663A
Authority
EC
Ecuador
Prior art keywords
compounds used
inhibitors
protein
compounds
pirazol
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Jean Damien Charrier
David Bebbington
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of ECSP034663A publication Critical patent/ECSP034663A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a la química medicinal y a los compuestos que son inhibidores protein quinasas, composiciones que contienen dichos compuestos y métodos de uso. Más particularmente, esta invención se refiere a compuestos que son inhibidores de Aurora -2 protein quinasas. La invención además se refiere a métodos para tratar enfermedades asociadas con protein quinasas, especialmente enfermedades asociadas con Aurora-2, tal como el cáncerThe present invention relates to medicinal chemistry and compounds that are protein kinase inhibitors, compositions containing said compounds and methods of use. More particularly, this invention relates to compounds that are inhibitors of Aurora -2 protein kinases. The invention further relates to methods for treating diseases associated with protein kinases, especially diseases associated with Aurora-2, such as cancer.

ECSP034663 2000-12-21 2003-06-20 PIRAZOL COMPOUNDS USED AS PROTEIN QUINASA INHIBITORS ECSP034663A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25788700P 2000-12-21 2000-12-21

Publications (1)

Publication Number Publication Date
ECSP034663A true ECSP034663A (en) 2003-07-25

Family

ID=34078813

Family Applications (2)

Application Number Title Priority Date Filing Date
ECSP034662 ECSP034662A (en) 2000-12-21 2003-06-20 PIRAZOL COMPOUNDS USED AS PROTEIN QUINASA INHIBITORS
ECSP034663 ECSP034663A (en) 2000-12-21 2003-06-20 PIRAZOL COMPOUNDS USED AS PROTEIN QUINASA INHIBITORS

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ECSP034662 ECSP034662A (en) 2000-12-21 2003-06-20 PIRAZOL COMPOUNDS USED AS PROTEIN QUINASA INHIBITORS

Country Status (2)

Country Link
EC (2) ECSP034662A (en)
ZA (8) ZA200304472B (en)

Also Published As

Publication number Publication date
ZA200304472B (en) 2004-06-25
ZA200304469B (en) 2004-06-24
ZA200304468B (en) 2004-06-24
ECSP034662A (en) 2003-07-25
ZA200304474B (en) 2004-06-25
ZA200304471B (en) 2004-06-24
ZA200304470B (en) 2004-06-24
ZA200304473B (en) 2004-06-24
ZA200304475B (en) 2004-06-24

Similar Documents

Publication Publication Date Title
BRPI0207961A8 (en) USE OF EPOTHYLONE AND CAPECITABIN ANALOGS TO MANUFACTURE DRUG TO TREAT SOLID CANCEROUS TUMORS AND KIT COMPRISING THE SAID COMPOUNDS.
UY27943A1 (en) COMPOSITIONS AND METHODS TO TREAT CRNCER USING ANTIBODY IMMUNOCATE PLAYS FOR CD44 CYTOTNXICS AND CHEMOTHERAPCUTIC AGENTS
BRPI0616630B8 (en) substituted pyrazole compounds
UY38742A (en) 2,3,5-PYRAZOLO [1,5-A] PYRIMIDINE TRISUSTITUED COMPOUNDS
ECSP077324A (en) BICYCLIC AMIDAS AS INHIBITORS OF CINASA
DK1537116T3 (en) Pyrazolopyrimidines suitable for the treatment of cancer diseases
CR9663A (en) 1,4-DIHYDROPIRIDINE-CONDENSED HETEROCICLES, PROCESSES TO PREPARE THE SAME, USE AND COMPOSITIONS CONTAINING THEM
CL2008003023A1 (en) (s) -4-amino-n- (1- (4-chlorophenyl) -3-hydroxypropyl) -1- (7h-pyrrolo [2,3-d] pyrimidin-4-yl) piperidine-4-carboxamide, inhibitor protein kinase b; preparation procedure; intermediate compounds; pharmaceutical composition comprising said compound; and use for the treatment of cancer.
SV2004001459A (en) 2- (PIRIDIN-2-ILAMINO) -PIRIDO [2,3-D] PIRIMIDIN-7-ONAS REF. PC20501
AR011116A1 (en) N-HYDROXY-BETA-SULFONIL PROPIONAMIDE DERIVED COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING IT
CR7716A (en) USE OF IKB-KINASE INHIBITORS FOR PAIN TREATMENT
ECSP034444A (en) DERIVATIVES OF 4-AMINO-6-PHENYL-PIRROLO (2,3-D) PYRIMIDINE
MXPA05012573A (en) Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors.
PA8468401A1 (en) COMPOUNDS FOR THE TREATMENT OF ISCHEMIA
DE60314623D1 (en) SUBSTITUTED PYRAZOLOPYRIMIDINES
BRPI0507644A (en) pyrazolopyrimidines as cyclin-dependent kinase inhibitors
TW200801008A (en) Protein kinase inhibitors
PE20070723A1 (en) IMIDAZOPYRAZINES AS INHIBITORS OF CYCLINE-DEPENDENT KINASES
SV2003001493A (en) SUBSTITUTED INDAZOLS, COMPOSITIONS THAT CONTAIN THEM, MANUFACTURING AND USE PROCEDURE
PA8593001A1 (en) PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH
DOP2004000949A (en) PIRROLO DERIVATIVES [3,4-C] PIRAZOL ASSETS AS KINASE INHIBITORS, PROCESS FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THE SAME
BRPI0412894A (en) thienopyridine and furopyridine kinase inhibitors
DK1255537T3 (en) Farnesyl protein transferase inhibitors for the treatment of breast cancer
CR9649A (en) AMINOPIRIMIDINS AS MODULAR CINASE
ECSP11005642A (en) NEW PIRAZOLOPIRIMIDINAS AS CYCLINE DEPENDENT QUINASA INHIBITORS